Antigen detection in the diagnosis and management of a patient with probable cerebral aspergillosis treated with voriconazole

Transplant Infectious Disease

Volumn 2, Issue 3, 2000, Pages 140-144

  Machetti, M ^a   Zotti, M ^a   Veroni, L ^a   Mordini, N ^a   Van Lint, M T ^a   Bacigalupo, A ^a   Paola, D ^a   Viscoli, C ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Antigen detection; Cerebral aspergillosis; Galactomannan; Voriconazole

Indexed keywords

ALANINE AMINOTRANSFERASE; AMPHOTERICIN B; ASPARTATE AMINOTRANSFERASE; GALACTOMANNAN; VORICONAZOLE;

ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ANTIGEN DETECTION; ARTICLE; ASPERGILLOSIS; BONE MARROW TRANSPLANTATION; CASE REPORT; DIAGNOSTIC VALUE; DRUG TOLERABILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER TOXICITY; PRIORITY JOURNAL;

ADOLESCENT; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS; BONE MARROW TRANSPLANTATION; DRUG THERAPY, COMBINATION; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; MAXILLARY SINUS; NEUROASPERGILLOSIS; PYRIMIDINES; TRIAZOLES;

EID: 0033811401     PISSN: 13982273     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3062.2000.020307.x     Document Type: Article

References (19)

1. Therapeutic outcome in invasive aspergillosis
2. Localization of aspergillosis to the central nervous system among patients with acute leukemia: Report of 14 cases. Gruppo Italiano Malattie Ematologiche dell'Adulto Infection Program
3. In vitro activity of a new antifungal triazole: UK-109, 496
4. In vitro studies of two triazole antifungal agents (voriconazole [UK-109,496] and fluconazole) against Candida species
5. A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei
6. UK-109, 496: A novel, wide-spectrum triazole derivative for the treatment of fungal infections: Antifungal activity and selectivity in vitro
7. Activity of voriconazole (UK-109,496) against clinical isolates of Aspergillus species and its effectiveness in an experimental model of invasive pulmonary aspergillosis
8. UK-109, 496, a novel, wide-spectrum triazole derivative for the treatment of fungal infections: Activity in systemic candidiasis models and early clinical efficacy in oropharyngeal candidiasis (OPC)
9. UK-109, 496 a novel, wide spectrum triazole derivative for the treatment of fungal infections: Clinical efficacy in acute invasive aspergillosis
10. UK-109, 496, a novel, wide-spectrum triazole derivative for the treatment of fungal infections: Clinical efficacy in chronic invasive aspergillosis - Interim analysis results
11. Serial monitoring of Aspergillus antigen in the early diagnosis of invasive aspergillosis. Preliminary investigations with two examples
12. A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis
13. Determination of a new antifungal agent, voriconazole, by multidimensional high-performance liquid chromatography with direct plasma injection onto a size-exclusion column
14. Comparison of an enzyme immunoassay and a latex agglutination system for the diagnosis of invasive aspergillosis in bone marrow transplant recipients
15. Serum Aspergillus galactomannan antigen testing by sandwich ELISA: Practical use in neutropenic patients
16. Prospective sandwich enzyme-linked immunosorbent assay for serum galactomannan: Early predictive value and clinical use in invasive aspergillosis
17. Sandwich enzyme-linked immunosorbent assay compared with Pastorex latex agglutination test for diagnosing invasive aspergillosis in immunocompromised patients
18. ELISA galactomannan antigen detection in CSF of patients with and without CNS Apergillosis
19. UK·109, 496, a novel, wide-spectrum triazole derivative for the treatment of fungal infections: Pharmacokinetics in man